Healthcare Business Strategy

Webinars

Value-Based Care in 2024: Anticipating Key Trends and Transformations

Brian Fuller, Managing Director of ATI Advisory’s Value-Based Care Design and Delivery practice, shared his observations on the evolution of value-based care during the webinar, “Value-based care in 2024: Anticipating Key Trends and Transformations.” 
Read More Read More
Webinars

Leadership Insights: A Conversation on the Year Ahead

On December 12, 2023, ATI Advisory founder and CEO Anne Tumlinson hosted the webinar “Leadership Insights: A Conversation on the Year Ahead” with Dan Mendelson, CEO of Morgan Health. During this conversation, Tumlinson and Mendelson discussed changes and investments they expect to see in healthcare in 2024.
Read More Read More
News

The Inflation Reduction Act Is Not Impacting Pharma R&D – Yet

Forbes columnist uses ATI Advisory analysis as basis for his latest column: "ATI Advisory was pretty thorough in compiling data for the first six months of 2023 using published information on 18 leading companies with respect to R&D budget changes, discontinuation of development candidates, and even M&A activity.
Read More Read More
Work

Pharma Innovation and the IRA: Report on the Top 19 Companies from the First Half of 2023

Since the Inflation Reduction Act (IRA) was passed in 2022, significant discussion has been devoted to its potential consequences for the development of new drugs. This report examines whether the IRA has had immediate impacts on drug development in the first half of 2023 through analysis of the companies’ R&D investments and M&A and licensing activities.
Read More Read More
Insights

CY2025 Medicare Advantage Proposed Rule

On November 6, 2023, CMS released its Contract Year 2025 Medicare Advantage and Part D Proposed Rule [CMS-4205-P]. ATI Advisory prepared a summary of key provisions and insights across D-SNP and dual eligible impacts, supplemental benefits, Part D formularies, network adequacy, agent and broker commissions, and equity-related provisions. The Rule has a heavy focus on beneficiary protections and program transparency.
Read More Read More
News

She has Medicare and Medicaid. So why should it take 18 months to get a wheelchair?

National Public Radio quotes Allison Rizer about the complexities that dually eligible face.
Read More Read More
1 2 3 4 9